Related Experiment Video
Updated: Jun 25, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Comprehensive ABC (HbA1c, blood pressure, LDL-C) control and cardiovascular disease risk in patients with type 2
Lovina A Naidoo1, Neil Butkow1, Paula Barnard-Ashton2
1Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Patients with type 2 diabetes mellitus (T2DM) and major depressive disorder (MDD) have poor control of glucose, blood pressure, and lipids (ABC). This increases their risk for cardiovascular disease (CVD) events.
Area of Science:
- Endocrinology
- Cardiology
- Psychiatry
Background:
- Suboptimal control of glucose (A), blood pressure (B), and lipids (C) in type 2 diabetes mellitus (T2DM) increases cardiovascular disease (CVD) risk.
- Major depressive disorder (MDD) is associated with poorer health outcomes.
- Integrated management of T2DM, ABC control, and MDD is crucial for CVD prevention.
Purpose of the Study:
- To evaluate the impact of MDD on ABC control in T2DM patients.
- To assess CVD risk factors in T2DM patients with and without MDD.
- To analyze T2DM management within a South African private healthcare context.
Main Methods:
- Retrospective analysis of medical claims and electronic health records.
- Inclusion of 1,211 adult patients with T2DM and/or MDD.
- Data collected for the year 2019.
Main Results:
- Only 13% of T2DM+MDD patients achieved simultaneous ABC targets, compared to 7.1% of T2DM-MDD patients.
- Higher macrovascular complication admission rates were observed in the T2DM+MDD group (22.8%) versus T2DM-MDD (13.1%).
- Older T2DM+MDD patients showed better glycated hemoglobin and LDL-C control, but significantly more had repeat macrovascular admissions (12% vs 2.9%).
Conclusions:
- Comprehensive ABC control remains suboptimal in T2DM patients, especially those with MDD.
- MDD exacerbates poor ABC control, elevating CVD risk in T2DM patients.
- Managed-care settings require improved strategies for integrated T2DM and MDD management to reduce CVD events.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Errors occurring during blood pressure monitoring
Several factors...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

